Events

Avis De Sécurité sur Dimension® clinical chemistry system

Selon Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (via FOI), ce/cet/cette avis de sécurité concerne un dispositif en/au/aux/à Slovenia qui a été fabriqué par Siemens Healthcare Diagnostics Inc..

Qu'est-ce que c'est?

Les avis de sécurité sont des communications que les fabricants de dispositifs médicaux ou leurs représentants font parvenir en particulier aux travailleurs du secteur médical, mais aussi aux utilisateurs de ces dispositifs. Les avis de sécurité concernent les actions entreprises quant aux dispositifs présents sur le marché et peuvent inclure des rappels et des alertes.

En savoir plus sur les données ici
  • Type d'événement
    Field Safety Notice
  • Pays de l'événement
    Slovenia
  • Source de l'événement
    AMPMDRS
  • Notes / Alertes
    Data from Slovenia is current through February 2019. All of the data comes from the Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (via FOI), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Slovenia.
  • Notes supplémentaires dans les données
  • Cause
    Siemens healthcare diagnostics has determined that dimension® creatinine (crea) may produce depressed results up to 12.7% (or approximately 0.2 mg/dl [18 µmol/l]) for a creatinine result at 1.5 mg/dl [133 µmol/l] when hemolysis exceeds 300 mg/dl [0.19 mmol/l] of hemoglobin. it is important to note that percent hemoglobin interference with dimension® crea is dependent on the creatinine concentration; at a creatinine concentration of 5.0 mg/dl [442 µmol/l], hemoglobin interference at concentrations up to a 1000 mg/dl [0.62 mmol/l] is < 10%. alternately, with an approximate bias of 0.2 mg/dl([18 µmol/l]), the percent hemoglobin interference may be higher at low creatinine concentrations (< 0.8 mg/dl [< 71 µmol/l]). .

Device

Dimension® clinical chemistry system

Manufacturer

Siemens Healthcare Diagnostics Inc.
  • Société-mère du fabricant (2017)
    Siemens Ag
  • Source
    AMPMDRS